Zhao X, Stabile B E, Mo J, Wang J, French S W
Department of Pathology, Harbor/UCLA Medical Center, Torrance, CA 90509, USA.
Arch Pathol Lab Med. 2001 Oct;125(10):1344-7. doi: 10.5858/2001-125-1344-NCWICT.
A coexisting of intraductal papillary mucinous hyperplasia (IPMH) and islet cell tumor with nesidioblastosis of the pancreas in a 51-year-old man is reported. All of the clinical data indicated an insulinoma. A distal pancreatectomy was performed. A discrete mass measuring 1.9 x 2.0 cm was grossly identified in the tail of the pancreas. There were no other gross lesions. An islet cell tumor with nesidioblastosis was confirmed by immunostains and ultrastructural study. In addition, an IPMH was found that involved mainly branches of the pancreatic duct. The islet cell tumor and IPMH were topographically separated; however, there was a histologically intimate relationship between the nesidioblastosis and the IPMH. These findings indicate that the IPMH may have derived from autocrine and paracrine influences on the existing duct epithelial cells. To the best of our knowledge, this is the first report of nesidioblastosis coexisting with islet cell tumor and IPMH.
报道了一名51岁男性胰腺导管内乳头状黏液性增生(IPMH)与胰岛细胞瘤伴胰岛母细胞增生症共存的病例。所有临床资料均提示为胰岛素瘤。行远端胰腺切除术。术中在胰腺尾部肉眼可见一个大小为1.9×2.0 cm的孤立肿块。未见其他肉眼可见病变。免疫染色和超微结构研究证实为胰岛细胞瘤伴胰岛母细胞增生症。此外,还发现了主要累及胰管分支的IPMH。胰岛细胞瘤与IPMH在解剖位置上相互分离;然而,胰岛母细胞增生症与IPMH在组织学上关系密切。这些发现表明,IPMH可能源于对现有导管上皮细胞的自分泌和旁分泌影响。据我们所知,这是首例胰岛母细胞增生症与胰岛细胞瘤及IPMH共存的报道。